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Background: We have developed a novel and practical cardiovascular magnetic resonance (CMR) technique to
evaluate left ventricular (LV) mitral annular motion by tracking the atrioventricular junction (AVJ). To test AVJ motion
analysis as a metric for LV function, we compared AVJ motion variables between patients with hypertrophic
cardiomyopathy (HCM), a group with recognized systolic and diastolic dysfunction, and healthy volunteers.
Methods: We retrospectively evaluated 24 HCM patients with normal ejection fractions (EF) and 14 healthy
volunteers. Using the 4-chamber view cine images, we tracked the longitudinal motion of the lateral and septal AVJ
at 25 time points during the cardiac cycle. Based on AVJ displacement versus time, we calculated maximum AVJ
displacement (MD) and velocity in early diastole (MVED), velocity in diastasis (VDS) and the composite index VDS/MVED.
Results: Patients with HCM showed significantly slower median lateral and septal AVJ recoil velocities during early
diastole, but faster velocities in diastasis. We observed a 16-fold difference in VDS/MVED at the lateral AVJ [median
0.141, interquartile range (IQR) 0.073, 0.166 versus 0.009 IQR −0.006, 0.037, P < 0.001]. Patients with HCM also
demonstrated significantly less mitral annular excursion at both the septal and lateral AVJ. Performed offline, AVJ
motion analysis took approximately 10 minutes per subject.
Conclusions: Atrioventricular junction motion analysis provides a practical and novel CMR method to assess mitral
annular motion. In this proof of concept study we found highly statistically significant differences in mitral annular
excursion and recoil between HCM patients and healthy volunteers.
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Atrioventricular plane displacement, a measure of longitu-
dinal left ventricular (LV) function, accounts for ap-
proximately 60% of the stroke volume [1]. Reduced
mitral annular plane systolic excursion (MAPSE), mea-
sured by M-mode echocardiography, provides a sensitive,* Correspondence: leon.axel@nyumc.org
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unless otherwise stated.early marker of systolic dysfunction in hypertensive pa-
tients with preserved EF, and can diagnose heart failure
with preserved EF [2]. Mitral annular velocity (E’), mea-
sured in early diastole by tissue Doppler echocardiog-
raphy, incrementally predicts cardiac mortality beyond
clinical data and standard echocardiographic measures
[3,4]. At the present time, however, there is still no sim-
ple, validated cardiovascular magnetic resonance (CMR)
technique to measure mitral annular excursion and
recoil.
In the current study we investigated the movement of
the atrioventricular junction (AVJ) throughout the cardiacd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
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points at the corresponding left atrial-ventricular junc-
tions in long axis cine images. The maximum longitudinal
displacement of the AVJ in systole corresponds to peak
mitral annular excursion. The maximum velocity of the
AVJ in early diastole reflects peak mitral annulus recoil
velocity during passive LV filling. We previously showed
that AVJ MVED represents a statistically significant CMR
correlate of tissue Doppler echocardiography E’ [5], and
we have confirmed these findings in a separate cohort of
patients from a different institution. We analyzed 27 pa-
tients who underwent both studies within 24 hours, and
again found a statistically significant (p = 0.001) correl-
ation between CMR-derived MVED and E’ (r = 0.624) [6].
To test our hypothesis that hearts with systolic and
diastolic dysfunction, despite preserved EF, would dem-
onstrate abnormal AVJ motion, we performed our ana-
lysis on patients with HCM. With the highest prevalence
of any genetic cardiac disorder, HCM affects approxi-
mately 1 in 500 individuals and may cause considerable
morbidity and mortality [7]. The disease is known to be
associated with diastolic [8] and regional LV systolic dys-
function [9].
Atrioventricular junction motion tracking software,
developed in our laboratory, measures the longitudinal
position of the AVJ on routinely obtained long axis cine
images as a function of time during the cardiac cycle.
Analysis of steady state free precession (SSFP) cine im-
ages provides better temporal resolution compared to
conventional phase-contrast imaging techniques [10]
used to evaluate myocardial velocity, without adding to
acquisition time. Performed offline, in an efficient man-




We retrospectively identified 30 consecutive patients be-
tween the ages of 21 and 64 with known or suspected
HCM who underwent CMR as part of their routine clin-
ical assessment at one of three affiliated hospitals (New
York University Langone Medical Center, Bellevue Hos-
pital Center, and the Manhattan Veteran’s Affairs Hos-
pital) between February 2006 and July 2011. Eligible
patients demonstrated LV hypertrophy (LVH) of at least
15 mm, not attributable to another etiology such as
hypertension or diabetes, in a minimum of one myocar-
dial segment. We excluded 5 patients without significant
LVH, and one patient with concomitant evidence of left
ventricular non-compaction. Prior to inception of the
current study, healthy volunteers with no significant past
medical history had been recruited to establish baseline
AVJ motion variable values. A total of 14 healthy volun-
teers without hypertension, diabetes mellitus, coronaryartery disease or other significant past medical history,
and all with normal CMR examinations, were matched
for mean age and used for comparison with the 24 HCM
patients. Institutional review board approval was granted,
and informed consent was obtained from all healthy
volunteers.
CMR protocol
As part of routine clinical protocol, HCM patients under-
went CMR evaluation on 1.5 T or 3 T systems (Avanto,
Tim Trio, Verio, Siemens, Erlangen, Germany) using a
torso phased-array receiver coil. Two-dimensional SSFP
pulse sequence cine imaging with electrocardiographic
gating was performed in multiplanar short and long axis
views, for evaluation of LV wall thickness, mass, seg-
mental wall motion and global systolic function. Contrast-
enhanced T1-weighted inversion-recovery late gadolinium
enhancement (LGE) imaging was acquired for evaluation
of myocardial fibrosis. Delayed imaging was performed
10 minutes after patients received intravenous gadolinium-
diethylenetriamine penta-acetic acid (0.15 mmol/kg)
contrast agent. Quantitative measurements of LV vol-
umes, EF and mass, as well as qualitative assessments of
LA size, severity of mitral regurgitation and systolic an-
terior motion of the mitral valve leaflets were per-
formed. Post-processing, including the measurement of
LV wall thickness, was performed on each segment of a
17-segment LV model, excluding the apical cap.
Healthy volunteers were imaged with a 3 T CMR system
(Tim Trio, Siemens, Erlangen, Germany), using standard
phased-array coils. Typical imaging parameters for pa-
tients and healthy volunteers included: TR = 2.4 ms,
TE = 1.4 ms, flip angle 51°, slice thickness = 6 mm, in-
plane spatial resolution = 1.6 mm × 1.6 mm, receiver
bandwidth = 930 Hz/pixel, 20–30 phases (average 25
phases) per cardiac cycle and temporal resolution ~ 45 ms.
To cover late diastolic filling, image acquisition was per-
formed throughout the cardiac cycle with retrospectively
gated reconstruction.
Image and data analyses
Atrioventricular motion was measured at the septal and
lateral junction points between the left atrium and ven-
tricle in the 4-chamber cine view. A reference line was
placed through the LV apex and the midpoint of the mitral
annulus (Figure 1). The AVJ demonstrated an arc-like mo-
tion with longitudinal (toward the apex) and radial (to-
ward the center of the mitral annulus) components. The
longitudinal displacement was effectively measured as the
distance between a perpendicular line through the refer-
ence line and AVJ at end diastole, and a perpendicular line
through the reference line and AVJ at the given time point
in the cardiac cycle. This distance was interactively mea-
sured over the cardiac cycle, using our custom-written
Figure 1 Septal and lateral AVJ. Yellow and red asterisks mark the
septal and lateral AVJ, respectively, on this 4-chamber view. A reference
line for longitudinal AVJ motion bisects the LV between the apex and
the midpoint of the mitral annulus. AVJ = atrioventricular junction;
LV = left ventricle.
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Standardized atrioventricular junction motion analysis
was performed off-line and took approximately 10 minutes
per subject.
All distances measured were divided by the longitu-
dinal length of the LV at end diastole to provide an ap-
proximate correction for individual heart sizes. The AVJ
was identified and marked on each of the cine phases
obtained (Figure 2), and several motion variables were
calculated (Figure 3). Based on the resulting time-
versus-displacement plot, the AVJ motion variable MD
(maximum displacement normalized by end-diastolicFigure 2 AVJ displacement-versus-time plot and images. Atrioventricu
longitudinal AVJ position at multiple time points during the cardiac cycle. E
mean of multiple independent measurements made on a representative h
shown at the start of systole (A), end systole (B), diastasis (C) and end dias
AVJ = atrioventricular junction.length) was determined. The slopes between sequential
points of the normalized displacement-versus-time
curve were calculated and plotted, resulting in a normal-
ized velocity-versus-time curve. The maximum normal-
ized velocity of the AVJ during early passive mitral filling
(MVED), and the best-fit line of normalized AVJ velocity
in diastasis (VDS) were also calculated. In order to estab-
lish intra-study reliability, AVJ motion analysis was also
performed in a previously described cohort of patients re-
ferred for CMR [5] using both 3- and 4-chamber long axis
cine images.
Statistical methods
The continuous AVJ motion variables are presented as
medians and IQR. Comparisons between AVJ motion
variables in healthy volunteers and HCM patients were
made using the Mann–Whitney U test. Box-and-whisker
plots were generated to graphically represent differences
between the two groups. Inter-reader variability analysis
was performed on the healthy volunteer cohort data ob-
tained by two independent observers. To assess intra-
study reproducibility, intraclass correlation coefficients
were also obtained in a separate cohort of patients that
was previously described [5]. SPSS Statistics Version 20
was used to carry out all statistical analysis.
Results
Patient characteristics and CMR parameters
The mean age of the HCM patients and healthy volun-
teers in the study was 45 (range 25–59) and 46 (range
31–64), respectively. The mean thickness of the max-
imally hypertrophied segment was found to be 23 mm
(range 16–32 mm). On average, each patient had 4.5
segments of myocardial hypertrophy (range 2–9). All
HCM patients were found to have normal or increased
EF (Table 1). Of the 24 patients analyzed, 18 (75%)lar junction motion tracking software interactively measures the
rror bars represent one standard deviation above and below the
ealthy volunteer. Lateral AVJ position, marked with a red asterisk,
tole (D) for a representative 4-chamber cine image set.
Figure 3 AVJ normalized velocity-versus-time plot. Derived from
the AVJ normalized displacement-versus-time plot (dotted), the AVJ
normalized velocity-versus-time plot (blue) shows the calculated AVJ
motion variables MVED and VDS, as indicated. The motion tracking
program directly calculates the MD from the AVJ normalized
displacement-versus-time plot. AVJ = atrioventricular junction;
MD=maximum displacement; MVED=maximum velocity early diastole;
VDS = velocity diastasis.
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four (17%), mixed apical and asymmetric septal hyper-
trophy, and two (8%), concentric LVH. The most com-
mon location of maximum hypertrophy was found to be
in the basal anteroseptum (9 patients, 38%). None of the
segments in the basal or mid lateral wall or the entire in-
ferior wall displayed maximum hypertrophy. Similarly,
the most common location of any LVH > 15 mm was the
basal anteroseptum (19 patients, 79%). Although there
were areas of hypertrophy noted in the anterolateral,Table 1 HCM clinical and CMR characteristics
Mean (Range or % Patients)
Age (years) 45 (25–59)
Women 4 (17)
BMI* (kg/m2) 26 (14–47)
Maximum hypertrophy (mm) 23 (16–32)
# Hypertrophied segments ≥ 15 mm 4.5 (2–9)
Presence SAM‡ 13 (62)
Presence MR§ 13 (57)
Presence LGE|| 20 (83)
LV EF¶ (%) 66 (58–81)
LVEDV# (mL) 160 (56–285)
LVEDVI** (mL/m2) 80 (43–134)
Presence LA† dilation 14 (70)
*BMI = body mass index; †LA = left atrium; #LVEDV = left ventricle end diastolic
volume; **LVEDI = left ventricle end diastolic volume index; ¶LV EF = left
ventricle ejection fraction; ||LGE = late gadolinium enhancement; §MR =mitral
regurgitation; ‡SAM = systolic anterior motion.inferolateral and inferior segments, the majority were
localized to the basal and mid anterior and septal
segments.
Late gadolinium enhancement
Of the 24 patients analyzed, 20 (83%) demonstrated re-
gions of LGE consistent with myocardial fibrosis. None
of the lateral wall segments showed evidence of LGE.
The most common location of fibrosis was found to be
in the basal anteroseptum (14 patients, 58%), followed
by the mid anteroseptum (12 patients, 50%). The major-
ity of hypertrophied segments demonstrated LGE. Of
the 19 patients with basal anteroseptal hypertrophy, 14
(74%) were found to have LGE.
AVJ motion analysis
We observed highly significant statistical differences in
all three AVJ motion variables (MD, MVED, and VDS)
and the composite index VDS/MVED, in patients with
HCM when compared to healthy volunteers (Table 2
and Figures 4 and 5). Patients with HCM demonstrated
significantly less normalized MD at the septal and the
lateral AVJ compared to healthy volunteers. Both the
septal and the lateral AVJ of patients with HCM recoiled
at significantly slower normalized maximum velocities (s−1)
in early diastole relative to healthy volunteers. Conversely,
during diastasis, AVJ motion showed significantly faster
normalized velocities in patients with HCM at both the
septal and lateral AVJ. We found a 16-fold difference in
the VDS/MVED ratio at the lateral AVJ and a 4-fold differ-
ence at the septal AVJ. Despite the far fewer number of
hypertrophied segments and no evidence of LGE in the
lateral wall, there were no statistically significant differ-
ences between the septal and lateral AVJ motion variables
within the HCM group. Similarly, when comparing septal
to the lateral AVJ motion variables within the healthy vol-
unteers, we observed no significant differences. Twenty of
24 (83%) HCM exhibited LGE. Comparing HCM patients
with and without LGE, we found no statistically significant
differences in any of the AVJ motion variables (MD,
MVED, VDS and VDS/MVED) at either septal or lateral
AVJ. In comparison to healthy volunteers however, both
HCM patients with and the four patients (17%) without
LGE demonstrated statistically significant differences in
MVED, VDS and VDS/MVED (Table 3 and Figure 6) at
both the septal and lateral AVJ. Our results demonstrate
good reproducibility, based on normal volunteer data intra-
class correlation coefficients obtained by two independent
observers of 0.84 (p < 0.001), 0.92 (p < 0.001), 0.84 (p = 0.001)
and 0.79 (p = 0.006) for MD, MVED, VDS and VDS/MVED,
respectively. Intra-study reliability analysis revealed intraclass
correlation coefficients of 0.84 (p < 0.001), 0.55 (p = 0.003),
0.78 (p < 0.001) and 0.47 (p = 0.023) for MD, MVED, VDS
and VDS/MVED, respectively.
Table 2 Comparison of median AVJ motion variables between healthy volunteers and HCM patients for the lateral and
septal AVJ
Median 25th percentile 75th percentile Median 25th percentile 75th percentile P
Lateral AVJ* Control HCM‡
MD§ −0.149 −0.165 −0.125 −0.107 −0.121 −0.083 <0.001
MVED|| (s−1) 1.082 0.854 1.343 0.506 0.395 0.634 <0.001
VDS¶ (s−1) 0.012 −0.008 0.037 0.067 0.047 0.078 <0.001
VDS/MVED 0.009 −0.006 0.037 0.141 0.073 0.166 <0.001
Septal AVJ Control HCM
MD −0.149 −0.173 −0.130 −0.116 −0.130 −0.100 <0.001
MVED (s−1) 0.947 0.628 1.033 0.537 0.406 0.635 0.001
VDS (s−1) 0.027 0.004 0.060 0.074 0.040 0.109 0.006
VDS/MVED 0.029 0.004 0.056 0.126 0.090 0.249 <0.001
*AVJ = atrioventricular junction; ‡HCM = hypertrophic cardiomyopathy; §MD =maximum displacement; ||MVED =maximum velocity early diastole;
¶VDS = velocity diastasis.
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AVJ motion tracking
We have demonstrated the feasibility of a novel and
practical CMR technique, developed in our laboratory,
to track longitudinal AVJ motion throughout the cardiac
cycle. Using this technique, several AVJ motion variables
relating to LV function can be measured. While novel to
CMR, these variables are derived from principles relevantA
Figure 4 HCM and healthy volunteer AVJ displacement-versus-time a
plotted as a function of time during the cardiac cycle in a representative H
demonstrates a significantly greater MD compared to the patient with HCM. B.
plots show a significantly decreased recoil velocity during early diastole (MVED) i
junction; HCM= hypertrophic cardiomyopathy; MD=maximum displacemento assessment of systolic and diastolic function by estab-
lished echocardiographic measurements.
The MD, measured from the displacement-versus-time
curve at end systole, reflects longitudinal mitral annular
excursion and corresponds to echocardiographic MAPSE.
Since mitral annular excursion occurs with longitudinal
LV contraction and MAPSE predicts EF [11], the MD vari-
able provides a measure of regional, longitudinal, as wellB
nd velocity-versus-time plots. A. Longitudinal AVJ displacement
CM patient (red) and healthy volunteer (black). The healthy volunteer
Derived from the displacement-versus-time curves, the velocity-versus-time
n the HCM patient compared to the healthy volunteer. AVJ = atrioventricular
t; MVED =maximum velocity early diastole.
Figure 5 Box plots of AVJ motion variables in HCM patients and healthy volunteers. The box plots display the sample minimum (lower
whisker), lower quartile (lower box subdivision), median (horizontal band), upper quartile (upper box subdivision), and sample maximum (upper
whisker) for each of the AVJ motion variables MD, MVED, VDS and VDS/MVED at the lateral and septal AVJs in healthy volunteers and HCM
patients. Circles indicate outliers. P≤ 0.006 for all. AVJ = atrioventricular junction; HCM = hypertrophic cardiomyopathy; MD =maximum
displacement; MVED =maximum velocity early diastole; VDS = velocity diastasis.
Table 3 Comparison of median AVJ motion variables
between healthy volunteers and HCM patients with and
without LGE
Lateral P P
AVJ* HCM‡ LGE§+ HCM LGE-
vs vs
Healthy Volunteers Healthy Volunteers
MD|| <0.001 NS
MVED¶ (s−1) <0.001 0.001
VDS# (s−1) <0.001 0.003
VDS/MVED <0.001 0.001
Septal P P
AVJ HCM LGE+ HCM LGE-
vs vs
Healthy Volunteers Healthy Volunteers
MD <0.001 NS
MVED (s−1) 0.001 0.032
VDS (s−1) 0.005 0.045
VDS/MVED <0.001 0.023
*AVJ = atrioventricular junction; ‡HCM= hypertrophic cardiomyopathy; §LGE = late
gadolinium enhancement; ||MD =maximum displacement; ¶MVED =maximum
velocity early diastole; #VDS = velocity diastasis.
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we normalized the MD variable by the longitudinal LV
length. Since the heart apex remains approximately sta-
tionary throughout the cardiac cycle, the normalized MD
corresponds approximately to the maximum systolic strain
derived by tissue Doppler echocardiography. The general
shape of the observed AVJ displacement-versus-time curve
resembles the expected strain-versus-time and LV volume-
versus-time curves.
We also measured MVED, the maximum normalized
velocity of the AVJ during the early, passive phase of dia-
stole. This variable is measured from the AVJ normal-
ized velocity-versus-time curve, which is derived by
measuring the slope between sequential time points on
the normalized displacement-versus-time curve. As we
previously showed, MVED represents a statistically sig-
nificant CMR correlate of mitral annulus E’ measured by
tissue Doppler echocardiography [5]. Since we normal-
ized the displacement measurements to the end-diastolic
longitudinal LV length, MVED also approximately corre-
sponds to maximum early diastolic strain rate measured
by tissue Doppler. Consequently, the general shape of the
AVJ velocity-versus-time curve resembles the expected
strain rate-versus-time curve. In contrast to strain and
strain rate measured by tissue Doppler, which detects
differences in velocity between two adjacent areas of
Figure 6 Box plots of AVJ motion variables in HCM patients with and without LGE compared to healthy volunteers. The box plots
display the sample minimum (lower whisker), lower quartile (lower box subdivision), median (horizontal band), upper quartile (upper box
subdivision), and sample maximum (upper whisker) for each of the AVJ motion variables MD, MVED, VDS and VDS/MVED at the lateral and septal
AVJ in healthy volunteers and HCM patients with and without LGE. Circles indicate outliers. Both HCM patients with and without LGE
demonstrated statistically significant differences (P < 0.05) in MVED, VDS and VDS/MVED at both the lateral and septal AVJ compared to
healthy volunteers. AVJ = atrioventricular junction; HCM = hypertrophic cardiomyopathy; LGE = late gadolinium enhancement; MD =
maximum displacement; MVED =maximum velocity early diastole; VDS = velocity diastasis.
Saba et al. Journal of Cardiovascular Magnetic Resonance 2014, 16:35 Page 7 of 9
http://jcmr-online.com/content/16/1/35myocardium, AVJ motion variables reflect changes in
position of a single material point. The AVJ can be ac-
curately tracked throughout the cardiac cycle, given the
excellent spatial resolution of CMR and the clear signal
intensity difference between myocardium and fat in the
adjacent atrioventricular groove.
We also measured the normalized velocity of the AVJ
in diastasis, VDS, by finding the best-fit line through the
normalized velocity-versus-time curve during the quies-
cent phase of diastole. The composite index VDS/MVED
was calculated to accentuate the individual differences in
the AVJ motion variables we noted when comparing pa-
tients with HCM to healthy volunteers.
AVJ motion variable comparison
While all HCM patients in our study demonstrated nor-
mal or increased EF, they showed decreased MD for
both the septal and lateral AVJ. As the MD corresponds
to longitudinal mitral annular excursion of a single point
at the AVJ, this may reflect altered regional rather than
global systolic function. Similar discrepancies between
global and regional systolic function had previously been
observed used tagged-CMR sequences in patients with
HCM [9]. In a pediatric population with HCM, Ganame
et al. [12] demonstrated regional differences in strain, al-
though global measures of systolic function were pre-
served. Reductions in longitudinal shortening in HCMmay be compensated for by an increase in LV torsion
[13], resulting in preserved global systolic function. When
comparing the septal versus lateral AVJ MD within the
HCM group, we found no significant differences despite
the relative sparing of hypertrophy and fibrosis in the
lateral wall. Our findings therefore suggest that regional
systolic dysfunction may be present in patients with
HCM, independent of hypertrophy, fibrosis and global
LV function.
As expected, we noted slower velocities of the septal
AVJ in HCM patients compared to healthy controls.
Somewhat unexpectedly, however, we also found slower
velocities of the lateral AVJ, despite the relative sparing
of hypertrophy and fibrosis in this region. When com-
paring the septal and lateral AVJ velocities within the
HCM group, we again found no significant differences.
These findings agree with the significantly lower septal
and lateral E’ velocities noted by Severino et al. [14]
when comparing individuals with HCM to healthy con-
trols. Another echocardiographic study demonstrated that
individuals with certain genotype (+) HCM, but without
morphologic evidence of LVH, exhibit significantly lower
systolic and early diastolic mitral annulus tissue Doppler
velocities compared to healthy controls [8]. These data
support a hypertrophy-independent mechanism for re-
gional systolic and diastolic dysfunction in patients with
HCM. The diffuse increase in collagen content of HCM
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by LGE, may contribute to myocardial dysfunction, as
we observed in the lateral wall segments of our patient
cohort. However, the four HCM patients without LGE
also demonstrated statistically significant differences in
MVED, VDS and VDS/MVED, at both the septal and
lateral AVJ, compared to healthy volunteers. These re-
sults further suggest that myocardial dysfunction may
occur in the absence of fibrosis detected by LGE. The
small sample size of HCM patients without LGE likely
precluded the demonstration of statistically significant
differences in MD. In contrast to HCM disease models
implicating abnormal myocyte contractility as the pri-
mary disturbance, an alternative ‘energy compromise’
hypothesis has been proposed. Crilley et al. [16] demon-
strated that abnormalities in myocyte energy metabolism
can occur in three different HCM genes, independent of
LVH, and therefore may affect energy-dependent pro-
cesses, such as the active relaxation phase of diastole. Im-
paired cardiomyocyte calcium handling, resulting from
alterations in a variety of signal transduction pathways,
can affect diastolic function as well [17].
We noted significantly higher normalized velocities of
both septal and lateral AVJ during diastasis in HCM pa-
tients, indicating the extension of relaxation and passive
filling into the normally quiescent phase of diastole. Ele-
vations in left atrial pressure may account in part for the
persistence of blood flow across the mitral annulus dur-
ing diastasis, and the correspondingly higher AVJ veloci-
ties in this phase of diastole. The higher velocities could
also represent a prolongation of the initial, normally
rapid relaxation phase of early diastole into the normally
quiescent period of mid-diastole. The increased mid-
diastolic velocities may be analogous to the L wave
noted on mitral inflow in certain patients with elevated
filling pressures. Interestingly, a small subset of patients
noted to have triphasic mitral inflow by Ha et al. [18]
carried the diagnosis of HCM.
Limitations
Our retrospective proof-of-concept study has several limi-
tations, including a small sample size of HCM patients,
which included only 4 women (17%). The cardiac MR stud-
ies performed on healthy volunteers did not include short
axis cine images, so LV EF, although qualitatively normal,
was not quantified. Although we previously demonstrated a
statistically significant correlation between MVED and tis-
sue Doppler echocardiography E’, AVJ motion and echo-
cardiography variables were not directly correlated in this
HCM cohort. However, the known E’ velocity reduction in
patients with HCM, in conjunction with the decreased
MVED we found associated with HCM and the two previ-
ous studies correlating E’ and MVED, indicate the rele-
vance of AVJ motion tracking findings in HCM.Conclusions
Atrioventricular junction motion tracking, a practical tech-
nique developed in our laboratory, assesses mitral annular
excursion and recoil by CMR. Using this novel approach,
we observed highly statistically significant differences in
AVJ motion variables in HCM patients compared to
healthy volunteers. Even with relative sparing of hyper-
trophy and LGE, the morphologically normal-appearing
HCM lateral wall also showed abnormal AVJ motion.
Atrioventricular junction motion analysis can be per-
formed efficiently on cine sequences that are obtained
in nearly all CMR evaluations, without the need for add-
itional acquisition time.
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